Gates Package — page 573

From: "Collins, Francis (NIH/OD) [E]" HB 2 04 nih. gov> To: "Fauci, Anthony (NIH/NIAID) [E]" HE oniaia nih. gov>, "Glass, Roger (NIH/FIC) )mail.nih.gov>, "Guttmacher, Alan (NIH/NICHD) [E]" il.nih.gov>, "Germino, Gregory (NIH/NIDDK) [E]" \niddk.nih.gov>, "Pettigrew, Roderic (NIH/NIBIB) [E]" il.nih.gov>, "Somerman, Martha (NIH/NIDCR) [E]" nih.gov>, "Austin, Christopher (NIH/NCATS mail.nih.gov>, "Varmus, Harold (NIH/NCI) [E nih.gov>, "Gibbons, Gary (NIH/NHLBI) [E]" \nih.gov>, "Insel, Thomas (NIH/NIMH) (E!' BBiemail nin. gov>, "Green, Eric (NIF/NHGRD [E]" fenheri nih gov> Ce: "Cantrel, Katherine )) [C]" HEE cniaia nih. gov>, "Conrad, Patricia onc aneen 'Stover, Kathleen C) [E]" ini ICR) [C]" MIR oh coe "Brown, (CHD) [C]" \nih.gov>, "Wilkerson, Anita D. (NIH/NIDDK) niddk.nih.gov>, "Poole, Charlene (NIH/NIDDK) [E]" JEXTRA.NIDDK.NIH.GOV>, "Brawley, David (NIH/NIDDK) [E]" nih.gov>, "Izzard, Tom IB) [C]" HE ow:i. ih. gov>, "Finnegan, Sean (CATS) [C]" ih.gov>, "Wiszneauckas, Joy (NIH/NC I [E]" od.nci.nih.gov>, "Togashi, Mieko (NIH/NCD [E]" exchange.nih.gov>, "Wells, Connie (NIH/NHLB! " )nhibi.nih.gov>, "Earle, Melod: BI) [E]" \nhibi.nih.gov>, "Sante, Annette (NIH/NHGRI) [C]" )mail.nih.gov>, "Rodela, Gloria (NIH/VRC) (E)" Bomail nin. gov>, "Subana, Tina (NIH/VRO) [E]" [omail nih gov>, "Lebron, Janette i = a. [c]" BEB oviaid nin. gov> 'McManus, Ayanna (NIH/OD) [E]" Jod.nih.gov>, "Eiss, Robert. TC) [E]" Howail.nin.gov>, "Burklow, John (NIH/OD) [E]" EE Nntcov> Subject: Agenda for Bill Gates visit to NIH on December 2 Date: Sun, 24 Nov 2013 12:38:32 -0500 Importance: Normal Attachments: Mundel_& Nikolic BIOs.doc; NIH_Briefing on Bill _and_Melinda_Gates_Foundation_Funding.doc; Program _for_Visit_of Bill _Gates_December_2_(3).docx; Wilson_Young_bios.docx Dear Colleagues, lam delighted you are able to join the roundtable discussion and working lunch with Bill Gates on Monday, December 2, from 12:15 AM-1:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with Bill and other staff from the Global Health Program at the BMGF. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than a series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format